Mice with human cancer could speed up AML treatment discovery

NCT ID NCT06782971

First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 24 times

Summary

This study aims to develop a faster way to test new drug combinations for acute myeloid leukemia (AML). Researchers will take blood and bone marrow samples from 25 AML patients and grow their cancer cells in special mice. They will then test how well standard and new treatments work in these mice and compare the results to what happens in the patients. The goal is to speed up discovery of better treatments for AML.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AML (ACUTE MYELOID LEUKEMIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Canberra Health Services

    RECRUITING

    Canberra, Australian Capital Territory, 2605, Australia

    Contact Email: •••••@•••••

  • Prince of Wales Hospital

    RECRUITING

    Sydney, New South Wales, 2031, Australia

    Contact

  • Royal North Shore Hospital

    NOT_YET_RECRUITING

    Sydney, New South Wales, 2065, Australia

    Contact

  • Westmead Hospital

    RECRUITING

    Westmead, New South Wales, 2145, Australia

    Contact

Conditions

Explore the condition pages connected to this study.